Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide
NCT00421694
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
119
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Bicalutamide
Sponsor
University of L'Aquila